Diagnostics | Free Full-Text | Vibration-Controlled Transient Elastography and Controlled Attenuation Parameter for the Diagnosis of Liver Steatosis and Fibrosis in Patients with Nonalcoholic Fatty Liver Disease | HTML
Controlled Attenuation Parameter (CAP): a noninvasive method for the detection of hepatic steatosis based on transient elastography - Myers - 2012 - Liver International - Wiley Online Library
FibroScan®, transient elastography for liver stiffness - ECHOSENS
The controlled attenuation parameter (CAP): A novel tool for the non-invasive evaluation of steatosis using Fibroscan® - ScienceDirect
Cureus | Accuracy of Ultrasound Elastography and Fibrosis-4 Index (FIB-4) in Ruling Out Cirrhosis in Obese Non-Alcoholic Fatty Liver Disease (NAFLD) Patients
Ultrasonography
Prospective comparison of transient elastography, MRI and serum scores for grading steatosis and detecting non-alcoholic steatohepatitis in bariatric surgery candidates - ScienceDirect
The FibroScan® Advantage in Early NASH Clinical Studies
Accuracy of controlled attenuation parameter (CAP) and liver stiffness measurement (LSM) for assessing steatosis and fibrosis in non-alcoholic fatty liver disease: A systematic review and meta-analysis - eClinicalMedicine
New diagnostic technique to evaluate hepatic steatosis using the attenuation coefficient on ultrasound B mode | PLOS ONE
![PDF] FibroScan (vibration-controlled transient elastography): where does it stand in the United States practice. | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/d1443873eaff02b60860bb714f18a57a40088a5c/2-Figure1-1.png "PDF] FibroScan (vibration-controlled transient elastography): where does it stand in the United States practice. | Semantic Scholar")
PDF] FibroScan (vibration-controlled transient elastography): where does it stand in the United States practice. | Semantic Scholar
FibroScan (Vibration-Controlled Transient Elastography): Where Does It Stand in the United States Practice - Clinical Gastroenterology and Hepatology
Performance characteristics of vibration‐controlled transient elastography for evaluation of nonalcoholic fatty liver disease - Vuppalanchi - 2018 - Hepatology - Wiley Online Library
Application of transient elastography in nonalcoholic fatty liver disease
Diagnostic of hepatic fibrosis with the XL probe of the Fibroscan versus biopsies in patients candidates to bariatric surgery - Clinical Nutrition ESPEN
Noninvasive imaging biomarker assessment of liver fibrosis by elastography in NAFLD | Nature Reviews Gastroenterology & Hepatology
Prevalence and factors associated with NAFLD detected by vibration controlled transient elastography among US adults: Results from NHANES 2017–2018 | PLOS ONE
IJMS | Free Full-Text | Elastography Techniques for the Assessment of Liver Fibrosis in Non-Alcoholic Fatty Liver Disease | HTML
Distribution of controlled attenuation parameter (CAP) values in... | Download Scientific Diagram
Vibration-controlled Transient Elastography for Assessment of Liver Fibrosis at a USA Academic Medical Center
Vibration-controlled transient elastography (VCTE) and controlled... | Download Scientific Diagram
Diagnostic accuracy of controlled attenuation parameter (CAP) as a non-invasive test for steatosis in suspected non-alcoholic fatty liver disease: a systematic review and meta-analysis | BMC Gastroenterology | Full Text
Controlled Attenuation Parameter (CAP): A Novel VCTE™ Guided Ultrasonic Attenuation Measurement for the Evaluation of Hepatic Steatosis: Preliminary Study and Validation in a Cohort of Patients with Chronic Liver Disease from Various
